DexCom, Inc. vs IDEXX Laboratories, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- IDEXX Laboratories, Inc. is the larger company by market value: $41.5 B against $29.9 B for DexCom, Inc., 1.4 times as much (market caps of Oct 22, 2026 for DexCom, Inc. and Oct 6, 2026 for IDEXX Laboratories, Inc.).
- DexCom, Inc. had more revenue: $4.7 B against $4.3 B for IDEXX Laboratories, Inc., both in the year to December 2025.
- IDEXX Laboratories, Inc. earned more: net income of $1.1 B against $836 M for DexCom, Inc.
- IDEXX Laboratories, Inc. keeps more of each dollar of sales: a net margin of 24.6% against 17.9% for DexCom, Inc.
- DexCom, Inc. employs more people: 11,100 against 10,780 at IDEXX Laboratories, Inc. Each employee brings in about $420,000 of revenue at DexCom, Inc. and $399,230 at IDEXX Laboratories, Inc.
- On price to earnings, IDEXX Laboratories, Inc. trades at 35.1× and DexCom, Inc. at 30.2×: investors pay more for each dollar of IDEXX Laboratories, Inc.'s profit.
- DexCom, Inc.'s revenue grew faster in its latest fiscal year: +15.6% against +10.4% for IDEXX Laboratories, Inc.
- Both are in the safe zone of the Altman Z-score.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | DexCom, Inc. DXCM · #854 in the world | IDEXX Laboratories, Inc. IDXX · #619 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics and Research | Diagnostics and Research |
| Founded | 1999 | 1983 |
| Size | ||
| Market cap | $29.9 B | $41.5 B |
| Revenue | $4.7 B | $4.3 B |
| Net income | $836 M | $1.1 B▲ best |
| Employees | 11,100 | 10,780 |
| Valuation | ||
| P/E ratio | 30.2× | 35.1× |
| Price to sales | 5.9× | 8.9× |
| Price to book | 10.9× | 25.9× |
| Free cash flow yield | 3.6%▲ best | 2.5% |
| Profitability | ||
| Gross margin | 60.1% | 61.8%▲ best |
| Operating margin | 19.6% | 31.6%▲ best |
| Net margin | 17.9% | 24.6%▲ best |
| Return on equity | 34.5% | 66.2%▲ best |
| Return on invested capital | — | 57.3% |
| Growth | ||
| Revenue growth | 15.6%▲ best | 10.4% |
| Revenue growth, 3 years a year | 17.0%▲ best | 8.5% |
| Earnings per share growth | 47.2%▲ best | 22.6% |
| Financial strength | ||
| Debt to equity | — | 0.3× |
| Net debt to EBITDA | — | 0.2× |
| Interest cover | 63.8× | — |
| Cash | ||
| Free cash flow margin | 23.1% | 24.6%▲ best |
| Shareholder returns | ||
| Shareholder yield | 1.7% | 2.9%▲ best |
| Strength scores | ||
| Piotroski F-score | — | 8 of 9 |
| Altman Z-score zone | safe | safe |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Oct 2026; ratios FY2025 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, DexCom, Inc. or IDEXX Laboratories, Inc.?
IDEXX Laboratories, Inc. is the larger company by market value: $41.5 B against $29.9 B for DexCom, Inc., 1.4 times as much (market caps of Oct 22, 2026 for DexCom, Inc. and Oct 6, 2026 for IDEXX Laboratories, Inc.).
Which makes more money, DexCom, Inc. or IDEXX Laboratories, Inc.?
DexCom, Inc. had more revenue: $4.7 B against $4.3 B for IDEXX Laboratories, Inc., both in the year to December 2025. IDEXX Laboratories, Inc. earned more: net income of $1.1 B against $836 M for DexCom, Inc.
Which is more profitable, DexCom, Inc. or IDEXX Laboratories, Inc.?
IDEXX Laboratories, Inc. keeps more of each dollar of sales: a net margin of 24.6% against 17.9% for DexCom, Inc.
Which has more employees, DexCom, Inc. or IDEXX Laboratories, Inc.?
DexCom, Inc. employs more people: 11,100 against 10,780 at IDEXX Laboratories, Inc. Each employee brings in about $420,000 of revenue at DexCom, Inc. and $399,230 at IDEXX Laboratories, Inc.
Is DexCom, Inc. cheaper than IDEXX Laboratories, Inc.?
On price to earnings, IDEXX Laboratories, Inc. trades at 35.1× and DexCom, Inc. at 30.2×: investors pay more for each dollar of IDEXX Laboratories, Inc.'s profit. A lower multiple is not by itself a better buy: it also reflects expected growth, risk and accounting.
Which is growing faster, DexCom, Inc. or IDEXX Laboratories, Inc.?
DexCom, Inc.'s revenue grew faster in its latest fiscal year: +15.6% against +10.4% for IDEXX Laboratories, Inc.
Which is financially stronger, DexCom, Inc. or IDEXX Laboratories, Inc.?
Both are in the safe zone of the Altman Z-score.
More about DexCom, Inc.
More about IDEXX Laboratories, Inc.
Sources#
Every figure on this page comes from these, with the date shown next to it.